In Brief: US Medical Products
This article was originally published in The Gray Sheet
Executive Summary
US Medical Products: Austin, Texas-based knee and hip prosthetic devices firm appoints Melville Engle president and CEO. Engle most recently served as senior VP of Allergan. Former President and CEO Michael Allen left the firm for personal reasons in March; Gary Mermelstein, VP of sales and marketing, who served as acting CEO in the interim, "will now focus entirely on marketing and distribution," the firm states...
You may also be interested in...
New EU Filings
Obecabtagene autoleucel, Autolus Therapeutics’s investigational treatment for relapsed or refractory B cell precursor acute lymphoblastic leukemia, is among the latest products that have been filed for review by the European Medicines Agency for potential EU marketing approval.
BMS Has A Strong Pipeline, But Access Challenges Remain
Bristol Myers Squibb’s head of major markets, Monica Shaw, wants to improve patients’ access to lifesaving therapies. And the group has several new products ready to roll.
Novartis Hires Ex-BMS Chief As It Pursues US Growth Strategy
The Swiss pharma company is looking to tap into the experience of ex-BMS leader Giovanni Caforio to help further it US-first commercial strategy.